- Home
- RYOJ vs INMB Comparison
RYOJ vs INMB Comparison
Compare RYOJ & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RYOJ | INMB |
|---|---|---|
| Founded | 2015 | 2015 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.6M | 39.6M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | RYOJ | INMB |
|---|---|---|
| Price | $4.20 | $2.03 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $5.40 |
| AVG Volume (30 Days) | 628.1K | ★ 1.1M |
| Earning Date | 12-15-2025 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 11.85 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $50,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $19.04 | ★ N/A |
| Revenue Growth | N/A | ★ 257.14 |
| 52 Week Low | $1.56 | $1.09 |
| 52 Week High | $11.43 | $3.24 |
Technical Indicators
Market Signals| Indicator | RYOJ | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 64.43 | 70.51 |
| Support Level | $1.97 | $1.21 |
| Resistance Level | $6.49 | $2.30 |
| Average True Range (ATR) | 0.67 | 0.17 |
| MACD | 0.18 | 0.04 |
| Stochastic Oscillator | 83.08 | 80.79 |
Price Performance
Historical ComparisonAbout RYOJ rYojbaba Co. Ltd.
rYojbaba Co Ltd is engaged in improving and restoring physical and mental health diminished by work-related stress through consulting and health services. The company provides consulting services to labor unions and companies wishing to build constructive relationships with labor unions and health services to osteopathic clinics and osteopathic beauty salons to alleviate physical ailments created by work-related stress.
About INMB INmune Bio Inc.
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.